Our Gratitude and Reflection for 2021

December 28, 2021
ATMA News

Hello,

‘Tis the season to sit back and reflect on the year behind us. To be with shorter days and spend time with friends and family.

What are you grateful for this past year?

At ATMA, it has been quite a year to be grateful. Health Canada has approved dozens of Section 56 Exemptions through many different Doctors, companies and non-profits ATMA is honored to be part of this. Thank you, Health Canada!

In December, ATMA supported four palliative applicants with their Psilocybin Therapy experience. What a gift to witness the breakthroughs happening in these sessions to experience the heart-opening and healing occurring with these clients is just magic!

Also, in December, in a ground-breaking fashion, Health Canada approved three exemptions for treatment-resistant anxiety, depression and PTSD, which is outstanding and slowly opening the door to helping more people.

ATMA is committed to helping create a foundation for Psilocybin Therapy to be part of mainstream therapy. Through our Healthcare Professional training program and experiential trials, we hope to support this new therapy becoming accessible.

Currently, ATMA is only accepting Section 56 Exemption applications for people with an end-of-life diagnosis.

Deep gratitude to all the Therapists, Doctors, Nurses, advocates, and other healthcare professionals for helping move the needle forward in this new therapy.

Thank you so much for being part of this great movement

Love and Light
The ATMA Journey Team

More News and Media:

ATMA’s First Psychedelic Training Program for Physicians and Prescribers begins April 14, 2023

As psychedelic therapy regulations are being implemented, drafted and discussed globally, the need to educate doctors, psychiatrists and prescribers in psychedelics is greater than ever.

What is 5-MeO-DMT?

What is 5-MeO-DMT? If you haven’t heard of 5-MeO-DMT, you’re not alone. The use of 5-MeO-DMT as a clinical and therapeutic medicine is relatively new and there are, so far,

What is Ketamine-Assisted Therapy?

Ketamine has been used in medical settings and is now getting more support for use in therapy applications. Here’s what you need to know about ketamine-assisted therapy. What is Ketamine?

Traditional Therapy vs. Psychedelic Therapy

With interest in psychedelic therapy increasing from potential practitioners and patients, there has been an increase in questions about psychedelic therapy. We’re here to help answer some of those burning

What is Ayahuasca-Assisted Therapy?

Ayahuasca has been used in healing sessions for thousands of years and is now making it’s way into western medicine and therapy settings. Here’s what you need to know about

What is Psilocybin-Assisted Therapy?

Psychedelic-assisted therapy is slowly becoming a legal therapy option across the US and Canada, with psilocybin-assisted therapy leading the way. But what is psilocybin and how is it used in

Importance of Introspection and Self Care Work for Therapists

Research has demonstrated that individuals in helping professions are highly susceptible to compassion fatigue and occupational burnout. Compassion Fatigue for Therapists Compassion fatigue is common in trauma therapists who may

Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists

First-of-its-kind clinical trial establishes the Company’s drug pipeline and strategic plan to supply thousands of therapists VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF)